ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Mammography Flap Heats Up Again RP Statistician Says New Rules Worse Than Old

December 10, 1976

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61

June 17, 2011

Cancer Groups Urge Support For Comprehensive Cancer Care Legislation.

June 29, 2007

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998